MedPath

Predictive Value of Whole Blood Coagulation Parameters for Post-discharge Venous Thromboembolism After Cancer Resection

Not Applicable
Terminated
Conditions
Venous Thromboembolism
Interventions
Other: blood tests
Registration Number
NCT01608919
Lead Sponsor
University of Colorado, Denver
Brief Summary

This study plans to learn more about the role of 2 blood tests in predicting who might develop a blood clot in their arm or leg after major surgery. The investigators know that patients who have cancer and major surgery have a higher than normal risk of getting blood clots in the veins of their arms or legs. This can be very dangerous because the clot can move into your lungs.

Detailed Description

Venous Thromboembolism (VTE) after cancer surgery hospitalization is the most common cause of death at 30 days after cancer surgery, and is a significant source of patient morbidity and health care cost. Pharmacoprophylaxis has proven efficacy in preventing post-discharge VTE in surgical cancer patients, but perceived risks and costs pose barriers to widespread adoption by clinicians. Risk stratification of this patient population is necessary to allow appropriate prescription of prophylaxis to the highest risk patients. Can the investigators develop a risk stratification model that includes a readily available laboratory test, the thromboelastogram with or without platelet mapping?

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
4
Inclusion Criteria
  • subjects who are having primary, open resection surgery of gastrointestinal or bladder cancer
Read More
Exclusion Criteria
  • currently receiving anticoagulation therapy
  • pregnant
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
diagnostic blood testsblood testsWe are using 2 standard approved blood tests that may be useful in predicting who may develop a venous thromboembolism after cancer surgery.
Primary Outcome Measures
NameTimeMethod
Venous thromboembolism free survival after surgery for gastrointestinal or urologic cancer3 months post-discharge from hospital
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

University of Colorado Hospital

🇺🇸

Aurora, Colorado, United States

© Copyright 2025. All Rights Reserved by MedPath